Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: USTR Special 301

Wrapping up 2019 – Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 30, 2019

Recent Posts

Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact
The US NIH will share technology with WHO to fight the pandemic
With technology transfer, 120 companies in low- and middle-income countries could manufacture mRNA vaccines
Wrapping up 2021 – some noteworthy medicines law and policy events

Posts by Subject

Access to Medicines ARIPO C-TAP Cancer CDCA competition law Compulsory licensing compulsory licensing for export covid-19 Covid-19 Pool Covid-19 vaccine Data exclusivity Delinkage DNDi dolutegravir essential medicines list European Commission European Union evergreening Fair Pricing Gilead Hepatitis C HIV IFPMA LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands Orphan Drugs Patents PrEP R&D remdesivir Sofosbuvir SPC Supplementary Protection Certificates The Netherlands TRIPS flexibilities TRIPS Waiver Truvada vaccines WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Home
Covid-19
Tools
TRIPS Flexibilities Database
Resources
Blog
About

This work is licensed under Creative Commons.